Free tool
Stocks far below their 52-week high
We cover 7 companies trading at least 50% below their own 52-week high. The median market value in the group is $104.59B. Across the group, the median move over the past trading day is −0.10%. Price change over the past year runs from −90.5% to −76.7% across the middle 80 percent of the group, with a median of −83.2%.
Other lists in this group
Table
7 of 4,095 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| GILD34.SA | Gilead Sciences, Inc. | $184.15B | Large cap | −79.11% |
| VRTX34.SA | Vertex Pharmaceuticals Incorporated | $139.70B | Large cap | −83.18% |
| MDTC34.SA | Medtronic plc | $118.37B | Large cap | −75.74% |
| M1CK34.SA | McKesson Corporation | $104.59B | Large cap | −92.49% |
| C1IC34.SA | The Cigna Group | $73.39B | Large cap | −85.33% |
| B1SX34.SA | Boston Scientific Corporation | $70.04B | Large cap | −89.24% |
| A1GI34.SA | Agilent Technologies, Inc. | $39.64B | Large cap | −77.37% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.